Kenichi Tanaka

Professor and Chair

University of Oklahoma Health Sciences Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Kenichi Tanaka is a Professor and Chair at The University of Oklahoma Health Sciences Center, USA. His research focuses on coagulation, transfusion medicine, and the clinical applications of hemostatic therapies, as evidenced by his recent publications on heparin resistance, perioperative practices in the United States, and platelet function testing in cardiac surgery. He is committed to exploring racial and ethnic disparities in transfusion practices and the use of factor concentrates in patients with bleeding disorders.

Articles (28)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (6)

Aaron S. Hess

UNITED STATES

View details

Bhavani S Kodali

University of Maryland School of Medicine

UNITED STATES

View details

Roman Sniecinski

Professor

Emory University School of Medicine

UNITED STATES

View details

Jerrold Levy

Professor and CoDirector Cardiothoracic ICU

Duke University School of Medicine

UNITED STATES

View details

Cheryl Maier

Emory University

UNITED STATES

View details

Robert DeSimone

Assistant Professor

Weill Cornell Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kenichi Tanaka

Research Interests

Explore related searches

Contact this professor

About

Articles (28)

Perioperative use of factor concentrates and blood products—a survey of clinical practices in the United States: communication from the ISTH Subcommittee on Perioperative and Critical Care

Thrombin Generation Assay in Pediatric Cardiac Surgery: A Prediction Tool or Not Ready for Prime Time?

Caution in Extrapolating in Vitro Heparin-Protamine Titration Data to Clinical Use

A prospective non‐inferiority trial of pathogen reduced platelets compared to non‐pathogen reduced platelets for correction of viscoelastic platelet function testing in cardiac surgery

Association of antepartum anemia and red blood cell mass with racial and ethnic disparities in transfusion rates after cesarean delivery: A retrospective cohort study

Andexanet-induced heparin resistance in cardiac surgery—a rapid review of case reports and series

Antithrombin Levels during Venoarterial ECMO: Comment

Finding a common definition of heparin resistance in adult cardiac surgery: communication from the ISTH SSC subcommittee on perioperative and critical care thrombosis and hemostasis

From Ancient Arsenal to an Anesthetic: Historical Roles of Hyoscyamine and Aconitine in Anesthesia

Heparin Resistance after Andexanet Alfa – Calling on Argatroban and Nafamostat for Rescue?

Preoperative risk prediction models for acute kidney injury after noncardiac surgery: are all models wrong, or can some be recalibrated and become useful? Comment on Br J Anaesth 2024;133: 508–518

Toward Better Anticoagulation Monitoring for Extracorporeal Membrane Oxygenation: Taking C-reactive Protein Out of the Equation?

Protocol for a phase 3, randomised, active-control study of four-factor prothrombin complex concentrate versus frozen plasma in bleeding adult cardiac surgery patients requiring coagulation factor replacement: the LEX-211 (FARES-II) trial

Rethinking Coagulation Activation during Extracorporeal Membrane Oxygenation: Insights from the Case of Mr. Hageman

Beyond Anemia and Transfusion of Red Blood Cells: Further Perspectives on Sex-Based Biologic Differences and Vascular Inflammation

Antithrombin supplementation attenuates heparin resistance in plasma spiked with Gla-domainless factor Xa S195A in vitro

Point-of-care testing for tranexamic acid efficacy: a proof-of-concept study in cardiac surgical patients

Use of coagulation factor concentrates and blood transfusion in cardiac surgery: a retrospective cohort study of adults with hereditary and acquired bleeding disorders

Patient blood management programmes: keeping the ball rolling

Trends and predictions of perioperative transfusion and venous thromboembolism in hepatectomy using a North American Registry

Protamine and Coagulopathy After Cardiopulmonary Bypass: May the Perfect Electrostatic Force Be With You

In response: Not all acute normovolemic hemodilutions are created equal

Randomised trials to improve haemostasis management for postpartum haemorrhage. Comment on Br J Anaesth 2023; 130: 165–74

Beware of heterogeneity when assessing the bleeding risk using multi‐specialty and multi‐year database

Impact of Preoperative Hematocrit, Body Mass Index, and Red Cell Mass on Allogeneic Blood Product Usage in Adult Cardiac Surgical Patients: Report From a Statewide Quality Initiative

Blood utilization in liver transplantation (BUILT): A multidisciplinary survey of transfusion practices

Walking a Thin Line

Efficacy of sonorheometry point of the care device in determining low fibrinogen levels in pregnant blood: an invitro dilution and reconstitution study

Collaborators (6)

Aaron S. Hess

Bhavani S Kodali

Roman Sniecinski

Jerrold Levy

Cheryl Maier

Robert DeSimone

Make your next move.